Scarica l'app Stockscreener
19.75
8.52%
1.55
Dopo l'orario di chiusura:
19.75
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$18.20
Aprire:
$18.35
Volume 24 ore:
3.34M
Relative Volume:
2.31
Capitalizzazione di mercato:
$974.98M
Reddito:
$230.59M
Utile/perdita netta:
$-96.37M
Rapporto P/E:
-10.09
EPS:
-1.9571
Flusso di cassa netto:
$-39.54M
1 W Prestazione:
+21.91%
1M Prestazione:
+3.19%
6M Prestazione:
-29.08%
1 anno Prestazione:
+21.76%
Intervallo 1D:
$18.20
$19.87
Intervallo di 1 settimana:
$16.32
$19.87
Portata 52W:
$14.69
$30.81
Staar Surgical Co Stock (STAA) Company Profile
Nome
Staar Surgical Co
Settore
Industria
Telefono
(626) 303-7902
Indirizzo
1911 WALKER AVE, MONROVIA, CA
Compare STAA vs ISRG, BDX, ALC, MDLN, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
STAA
Staar Surgical Co
|
19.75 | 898.46M | 230.59M | -96.37M | -39.54M | -1.9571 |
|
ISRG
Intuitive Surgical Inc
|
494.02 | 174.76B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
182.49 | 52.44B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
84.13 | 40.70B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
MDLN
Medline Inc
|
49.99 | 40.28B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
RMD
Resmed Inc
|
251.63 | 37.99B | 5.40B | 1.49B | 1.78B | 10.12 |
Staar Surgical Co Stock (STAA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-03 | Iniziato | Wedbush | Neutral |
| 2026-01-16 | Ripresa | Morgan Stanley | Underweight |
| 2025-04-21 | Iniziato | Wells Fargo | Equal Weight |
| 2025-02-12 | Downgrade | BTIG Research | Buy → Neutral |
| 2025-02-12 | Downgrade | Jefferies | Buy → Hold |
| 2025-02-12 | Downgrade | Mizuho | Outperform → Neutral |
| 2025-02-12 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2024-07-15 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2024-06-11 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2024-03-11 | Aggiornamento | Stifel | Hold → Buy |
| 2023-12-05 | Downgrade | Needham | Buy → Hold |
| 2023-12-04 | Iniziato | Morgan Stanley | Equal-Weight |
| 2023-09-15 | Downgrade | The Benchmark Company | Buy → Hold |
| 2023-08-03 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2023-06-07 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-04-17 | Iniziato | Piper Sandler | Neutral |
| 2023-02-06 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-12-28 | Reiterato | BTIG Research | Buy |
| 2022-12-08 | Iniziato | Stifel | Hold |
| 2022-11-07 | Aggiornamento | Sidoti | Neutral → Buy |
| 2022-10-14 | Ripresa | Stephens | Overweight |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2022-04-08 | Iniziato | Needham | Buy |
| 2022-03-28 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2022-03-18 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2021-07-09 | Iniziato | Oppenheimer | Perform |
| 2021-01-19 | Downgrade | The Benchmark Company | Buy → Hold |
| 2020-10-26 | Downgrade | Sidoti | Buy → Neutral |
| 2020-08-31 | Aggiornamento | Sidoti | Neutral → Buy |
| 2020-08-06 | Reiterato | The Benchmark Company | Buy |
| 2020-07-06 | Downgrade | Sidoti | Buy → Neutral |
| 2020-06-24 | Downgrade | BTIG Research | Buy → Neutral |
| 2020-06-15 | Iniziato | Jefferies | Buy |
| 2019-12-04 | Iniziato | BTIG Research | Buy |
| 2018-09-24 | Reiterato | The Benchmark Company | Buy |
| 2018-08-06 | Ripresa | The Benchmark Company | Buy |
| 2017-11-20 | Reiterato | The Benchmark Company | Buy |
| 2017-08-14 | Reiterato | The Benchmark Company | Buy |
| 2017-03-03 | Reiterato | The Benchmark Company | Buy |
| 2016-05-18 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2013-09-10 | Ripresa | The Benchmark Company | Buy |
| 2013-02-28 | Reiterato | The Benchmark Company | Buy |
| 2012-11-01 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2012-03-02 | Iniziato | Northland Securities | Outperform |
| 2011-10-25 | Reiterato | The Benchmark Company | Buy |
| 2010-10-12 | Iniziato | Morgan Joseph | Buy |
| 2010-05-11 | Iniziato | Benchmark | Buy |
Mostra tutto
Staar Surgical Co Borsa (STAA) Ultime notizie
Eye lens maker STAAR Surgical sets March 3 call on 2025 results, China recovery - Stock Titan
FDA expands age indication for STAAR’s EVO ICL to patients aged 21–60 years - Optometry Times
STAAR Surgical Company (STAA) Stock Analysis: Navigating Growth Amidst a 27.10% Potential Upside - DirectorsTalk Interviews
FDA approves expanded age indication for STAAR's EVO/EVO+ Visian ICLs - Eyes On Eyecare
STAA Gains FDA Nod to Expand EVO ICL Age Indication to 60 Years - Yahoo Finance
FDA Approves Expanded Age Range for STAAR Surgical’s EVO ICL for Vision Correction - VisionMonday.com
Alcon launches TOTAL30 Multifocal for Astigmatism toric contact lens - Eyes On Eyecare
Midday Stock Roundup: Staar Surgical up on FDA approval - Orange County Business Journal
FDA expands age indication for Staar Surgical EVO ICL - MassDevice
Why Is Staar Surgical Stock Gaining Wednesday?Staar Surgical (NASDAQ:STAA) - Benzinga
Staar Surgical Gains Key FDA Approval to Broaden Patient Eligibility - AD HOC NEWS
FDA approved expanded age indication for EVO/EVO+ Visian implantable lenses - TipRanks
STAAR Surgical (STAA) Expands Lens Use with FDA Approval - GuruFocus
FDA expands U.S. age indication for EVO ICL - marketscreener.com
FDA clears STAAR eye lens for ages 21–60, opening option for 8M more - Stock Titan
New Alcon lens helps aging eyes stay in contacts all month - Stock Titan
Credit Industriel ET Commercial Invests $3.26 Million in STAAR Surgical Company $STAA - MarketBeat
3 Low-Volatility Stocks We Find Risky - Finviz
New York Life Investment Management LLC Takes Position in STAAR Surgical Company $STAA - MarketBeat
STAAR Surgical Company (STAA) Stock Analysis: Exploring a 37.81% Potential Upside for Investors - DirectorsTalk Interviews
Alpine Associates Management Inc. Acquires Shares of 913,087 STAAR Surgical Company $STAA - MarketBeat
VIEW Optometry launches to support independent practices - Eyes On Eyecare
STAAR Surgical Company (NASDAQ:STAA) Given Average Recommendation of "Reduce" by Analysts - MarketBeat
212,421 Shares in STAAR Surgical Company $STAA Acquired by Versor Investments LP - MarketBeat
Eli Lilly To Rally More Than 21%? Here Are 10 Top Analyst Forecasts For Monday - Benzinga
STAAR Surgical (NASDAQ:STAA) Given New $19.00 Price Target at Stifel Nicolaus - MarketBeat
Staar Surgical price target lowered to $19 from $28 at Stifel - TipRanks
Leadership watch: Staar Surgical names co-CEOs, ACET adds to Board - Eyes On Eyecare
STAAR Surgical stock price target lowered to $19 by Stifel on China concerns By Investing.com - Investing.com India
STAAR Surgical stock price target lowered to $19 by Stifel on China concerns - Investing.com Nigeria
Staar Surgical CoEnters agreement with Chief Legal Officer Nathaniel SisitskySEC filing - marketscreener.com
STAAR Surgical Company (STAA): A Bull Case Theory - Finviz
Staar Surgical initiated with a Neutral at Wedbush - TipRanks
STAAR Surgical sinks as it plans to terminate sale to Alcon (update) - MSN
Staar Surgical (STAA) to Report Q4 Results: Wall Street Expects Earnings Growth - Finviz
STAA Receives Neutral Rating as Wedbush Initiates Coverage | STA - GuruFocus
STAAR names interim co-CEOs amid search for permanent leader - MedTech Dive
STAAR Surgical (NASDAQ:STAA) Now Covered by Wedbush - MarketBeat
STAAR Surgical (STAA) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
STAAR Surgical Names Warren Foust and Deborah Andrews Interim Co-CEOs - VisionMonday.com
Why STAAR Surgical (STAA) stock is trading lower today - MSN
Staar Surgical names interim co-CEOs in leadership shift following failed Alcon deal - massdevice.com
Why STAAR Surgical (STAA) Shares Are Down Today - Bitget
Why STAAR Surgical (STAA) Stock Is Trading Lower Today - Finviz
Staar Surgical Appoints Interim Co-CEOs - Orange County Business Journal
STAAR Surgical Appoints Warren Foust and Deborah Andrews Interim Co-CEOs - PharmiWeb.com
New weekly contact lens offers Canadians 16 hours of daily comfort - stocktitan.net
Staar Surgical appoints Warren Foust & Deborah Andrews interim co-CEOs - marketscreener.com
STAAR Surgical Company Announces Interim Co-CEO Appointments, Effective February 1, 2026 - marketscreener.com
Staar Surgical (STAA) Appoints Interim Co-CEOs as CEO Search Beg - GuruFocus
A month after Alcon deal fell through, Staar Surgical searches for next CEO and names interim leaders - Fierce Biotech
Staar Surgical Co Azioni (STAA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.06%
0.12%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):